INTERNATIONAL PATENT: SEAGEN INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER USING FUSION PROTEINS SPECIFIC FOR CD137 AND CD228"

GENEVA, Aug. 26 -- SEAGEN INC. (21823 30th Drive SEBothell, Washington 98021) filed a patent application (PCT/US2025/015963) for "METHODS OF TREATING CANCER USING FUSION PROTEINS SPECIFIC FOR CD137 AND CD228" on Feb 14, 2025. With publication no. WO/2025/175123, the details related to the patent application was published on Aug 21, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SAUER, Jeremy (c/o Seagen Inc.21823 30th Drive SEBothell, Washington 98021)

Abstract: The disclosure provides methods for treating cancer using fusion proteins that bind both CD137 and CD228.

For more informati...